Gly-Gly-Leu tripeptide reduced arterial calcification in non-human primates
A drug candidate previously effective in fatty liver disease reduced atherosclerosis in large mammals according to a news report, and Gokhan notes a glycine-glycine-leucine tripeptide significantly reduced calcification in non-human primates.